Pharmaceutical and biotechnology companies use laboratory filtration products for making new drugs. The importance of drugs based on biotechnology is expected to grow. According to Evaluate Pharma, biotechnology products will account for 37% of the total prescription and OTC sales in 2026, up from 30% in 2020. By 2026, biotechnology will account for more than half the 100 top-selling medicines (Source: Evaluate Pharma).
Global laboratory filtration market size is projected to reach USD 5.3 billion by 2026 from USD 3.6 billion in 2021, at a CAGR of 7.8% from 2021 to 2026.
Based on product, the market is segmented into filtration media (filter papers, membrane filters, syringe and syringeless filters, filtration microplates, and other filtration media), filtration assemblies (microfiltration assemblies, reverse osmosis assemblies, ultrafiltration assemblies, vacuum filtration assemblies, and other filtration assemblies), and filtration accessories (filter holders, filter funnels, filter flasks, membrane dispensers, filter housings, cartridges, vacuum pumps, seals, and other filtration accessories).
Request for Sample PDF @ https://www.marketsandmarkets.com/requestsampleNew.asp?id=12936082
The filtration media segment accounted for the largest market share in 2018. The major factors driving market growth in this segment are the wider application of filtration media in processes such as sterilizing, final filtration, sample preparation, filtration of aqueous & organic solutions, fluid monitoring, and venting & gas filtration, as well as the increasing R&D activities in the biopharmaceutical & pharmaceutical industries.
Based on end user, the market is segmented into pharmaceutical & biopharmaceutical companies, the food & beverage industry, hospitals & diagnostic laboratories, and academic & research institutions. The pharmaceutical & biotechnology companies segment accounted for the largest market share in 2020. The high adoption of lab filtration in pharmaceutical & biotechnology companies for the development of large drug molecules accounts for the large share of this segment. Furthermore, increasing regulations for the manufacturing of defect-free end products will also drive focus on quality control measures in the pharmaceutical & biotechnology industry and, thereby, support market growth
The prominent players in the market are Merck Millipore (US), Danaher Corporation (US), Sartorius AG (Germany), 3M Company (US), GEA GROUP AKTIENGESELLSCHAFT (Germany), Steris (US), Thermo Fisher Scientific (US), Veolia Water Technologies (France), Avantor, Inc. (US), GVS S.p.A (Italy), MANN+HUMMEL (Germany), Agilent Technologies, Inc. (US), Ahlstrom-Munksjö (Finland), MACHEREY-NAGEL GmbH & Co. KG (Germany), AMD Manufacturing, Inc. (Canada), Koch Membrane Systems (US), Cole-Parmer (US), AQUAPORIN A/S (Denmark), and Sterlitech Corporation (US).
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12936082
Merck Millipore (US) is one of the prominent players in the global laboratory filtration market. The company is a supplier of lab materials, services, and technologies for the research, development, and production of pharmaceutical & biotechnology drug therapies. The company also has an extensive distribution channel across the globe. The company operates through three major segments—Healthcare, Life Science, and Performance Materials. The Life Science segment is subcategorized into Process Solutions, Research Solutions, and Applied Solutions. The Process Solutions segment provides laboratory filtration systems and products. Merck Millipore focuses on product development to enhance its presence and aims to strengthen its geographic presence via organic and inorganic growth strategies such as expansions and acquisitions.
North America was the largest regional market for laboratory filtration in 2020.
The global laboratory filtration market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of 37.4% of the global laboratory filtration market, followed by Europe with a share of 30.0%. The large share of the North American region can be attributed to a large number of pharmaceutical & biotechnology and food & beverage companies in the region, the presence of a well-established healthcare market, and the stringent regulatory scenario in the pharmaceutical industry.
Get More Insights @ https://www.prnewswire.com/news-releases/laboratory-filtration-market-worth-5-3-billion-by-2026--exclusive-report-by-marketsandmarkets-301424146.html
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com